Literature DB >> 11689130

Validation of FLIPR membrane potential dye for high throughput screening of potassium channel modulators.

K L Whiteaker1, S M Gopalakrishnan, D Groebe, C C Shieh, U Warrior, D J Burns, M J Coghlan, V E Scott, M Gopalakrishnan.   

Abstract

A fluorescence-based assay using the FLIPR Membrane Potential Assay Kit (FMP) was evaluated for functional characterization and high throughput screening (HTS) of potassium channel (ATP-sensitive K+ channel; K(ATP)) modulators. The FMP dye permits a more sensitive evaluation of changes in membrane potential with a more rapid response time relative to DiBAC4(3). The time course of responses is comparable to ligand-evoked activation of the channel measured by patch-clamp studies. The pharmacological profile of the K+ channel evaluated by using reference K(ATP) channel openers is in good agreement with that derived previously by DiBAC4(3)-based FLIPR assays. Improved sensitivity of responses together with the diminished susceptibility to artifacts such as those evoked by fluorescent compounds or quenching agents makes the FMP dye an alternative choice for HTS screening of potassium channel modulators.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11689130     DOI: 10.1177/108705710100600504

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  21 in total

Review 1.  High throughput screening technologies for ion channels.

Authors:  Hai-bo Yu; Min Li; Wei-ping Wang; Xiao-liang Wang
Journal:  Acta Pharmacol Sin       Date:  2015-12-14       Impact factor: 6.150

2.  A novel method for patch-clamp automation.

Authors:  D Vasilyev; T Merrill; A Iwanow; J Dunlop; M Bowlby
Journal:  Pflugers Arch       Date:  2006-04-05       Impact factor: 3.657

3.  Hydrogen sulfide as endothelium-derived hyperpolarizing factor sulfhydrates potassium channels.

Authors:  Asif K Mustafa; Gautam Sikka; Sadia K Gazi; Jochen Steppan; Sung M Jung; Anil K Bhunia; Viachaslau M Barodka; Farah K Gazi; Roxanne K Barrow; Rui Wang; L Mario Amzel; Dan E Berkowitz; Solomon H Snyder
Journal:  Circ Res       Date:  2011-10-06       Impact factor: 17.367

4.  A Comparison of the Ability of Leu8- and Pro8-Oxytocin to Regulate Intracellular Ca2+ and Ca2+-Activated K+ Channels at Human and Marmoset Oxytocin Receptors.

Authors:  Marsha L Pierce; Suneet Mehrotra; Aaryn C Mustoe; Jeffrey A French; Thomas F Murray
Journal:  Mol Pharmacol       Date:  2019-02-09       Impact factor: 4.436

5.  Novel cell-free high-throughput screening method for pharmacological tools targeting K+ channels.

Authors:  Zhenwei Su; Emily C Brown; Weiwei Wang; Roderick MacKinnon
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-18       Impact factor: 11.205

6.  Identification of novel inhibitors of the amino acid transporter B0 AT1 (SLC6A19), a potential target to induce protein restriction and to treat type 2 diabetes.

Authors:  Qi Cheng; Nishank Shah; Angelika Bröer; Stephen Fairweather; Yang Jiang; Dieter Schmoll; Ben Corry; Stefan Bröer
Journal:  Br J Pharmacol       Date:  2017-02-14       Impact factor: 8.739

7.  Extracts of edible and medicinal plants damage membranes of Vibrio cholerae.

Authors:  Eduardo Sánchez; Santos García; Norma Heredia
Journal:  Appl Environ Microbiol       Date:  2010-08-27       Impact factor: 4.792

8.  Sodium channel activation augments NMDA receptor function and promotes neurite outgrowth in immature cerebrocortical neurons.

Authors:  Joju George; Shashank M Dravid; Anand Prakash; Jun Xie; Jennifer Peterson; Sairam V Jabba; Daniel G Baden; Thomas F Murray
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

9.  Comparison of the pharmacological profiles of arginine vasopressin and oxytocin analogs at marmoset, macaque, and human vasopressin 1a receptor.

Authors:  Marsha L Pierce; Jeffrey A French; Thomas F Murray
Journal:  Biomed Pharmacother       Date:  2020-03-04       Impact factor: 6.529

10.  Characterization of BK channel splice variants using membrane potential dyes.

Authors:  F Saleem; I C M Rowe; M J Shipston
Journal:  Br J Pharmacol       Date:  2008-12-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.